Cargando…

Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial

OBJECTIVE: To validate GATHER-1 inclusion criteria and the study’s primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility. DESIGN: Post hoc analysis of phase II/III clinical trial. SUBJECTS: All 286 participants inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Angela S., Myers, Justin, Stinnett, Sandra S., Grewal, Dilraj S., Jaffe, Glenn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587635/
https://www.ncbi.nlm.nih.gov/pubmed/37868797
http://dx.doi.org/10.1016/j.xops.2023.100383
_version_ 1785123411001868288
author Li, Angela S.
Myers, Justin
Stinnett, Sandra S.
Grewal, Dilraj S.
Jaffe, Glenn J.
author_facet Li, Angela S.
Myers, Justin
Stinnett, Sandra S.
Grewal, Dilraj S.
Jaffe, Glenn J.
author_sort Li, Angela S.
collection PubMed
description OBJECTIVE: To validate GATHER-1 inclusion criteria and the study’s primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility. DESIGN: Post hoc analysis of phase II/III clinical trial. SUBJECTS: All 286 participants included in the GATHER-1 study. METHODS: For each subject, blue-light fundus autofluorescence (FAF), color fundus photographs, fluorescein angiograms, and OCT scans were obtained on the study eye and fellow eye. Geographic atrophy area and other lesion characteristics were independently graded by 2 experienced primary readers. If the 2 readers differed on gradeability, GA area (> 10%) or other lesion characteristics, the image was graded by an arbitrator whose measurement or characterization was the final grade. MAIN OUTCOME MEASURES: The main outcome measures were gradeability and reproducibility of FAF imaging data. Imaging data included lesion area, confluence of GA with peripapillary atrophy (PPA), whether GA involved the foveal centerpoint, and type of hyperautofluorescence pattern. RESULTS: A total of 2004 images (1002 visits, 286 participants) were analyzed. Gradeability (90.5%) and interreader gradeability concordance (90.2%) were high across all visits. Study eye images were more gradable compared with fellow-eye images. A greater proportion of smaller lesions required arbitration, but interreader reproducibility was consistently high for all images. There was no difference in gradeability, gradeability concordance, or lesion-area concordance for images with PPA-confluent GA compared with those with nonconfluent PPA. Foveal centerpoint-involving lesions had lower gradeability and lesion-area concordance. Images with diffuse patterns of hyperautofluorescence had better gradeability and gradeability concordance than those with nondiffuse patterns but had no difference in lesion-area or lesion-area concordance. CONCLUSIONS: There is high gradeability and excellent reproducibility measures across all images. These data support the validity of conclusions from GATHER-1 and the chosen inclusion criteria and end point. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
format Online
Article
Text
id pubmed-10587635
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105876352023-10-21 Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial Li, Angela S. Myers, Justin Stinnett, Sandra S. Grewal, Dilraj S. Jaffe, Glenn J. Ophthalmol Sci Original Article OBJECTIVE: To validate GATHER-1 inclusion criteria and the study’s primary anatomic end point by assessing the reproducibility of geographic atrophy (GA) measurements and factors that affect reproducibility. DESIGN: Post hoc analysis of phase II/III clinical trial. SUBJECTS: All 286 participants included in the GATHER-1 study. METHODS: For each subject, blue-light fundus autofluorescence (FAF), color fundus photographs, fluorescein angiograms, and OCT scans were obtained on the study eye and fellow eye. Geographic atrophy area and other lesion characteristics were independently graded by 2 experienced primary readers. If the 2 readers differed on gradeability, GA area (> 10%) or other lesion characteristics, the image was graded by an arbitrator whose measurement or characterization was the final grade. MAIN OUTCOME MEASURES: The main outcome measures were gradeability and reproducibility of FAF imaging data. Imaging data included lesion area, confluence of GA with peripapillary atrophy (PPA), whether GA involved the foveal centerpoint, and type of hyperautofluorescence pattern. RESULTS: A total of 2004 images (1002 visits, 286 participants) were analyzed. Gradeability (90.5%) and interreader gradeability concordance (90.2%) were high across all visits. Study eye images were more gradable compared with fellow-eye images. A greater proportion of smaller lesions required arbitration, but interreader reproducibility was consistently high for all images. There was no difference in gradeability, gradeability concordance, or lesion-area concordance for images with PPA-confluent GA compared with those with nonconfluent PPA. Foveal centerpoint-involving lesions had lower gradeability and lesion-area concordance. Images with diffuse patterns of hyperautofluorescence had better gradeability and gradeability concordance than those with nondiffuse patterns but had no difference in lesion-area or lesion-area concordance. CONCLUSIONS: There is high gradeability and excellent reproducibility measures across all images. These data support the validity of conclusions from GATHER-1 and the chosen inclusion criteria and end point. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. Elsevier 2023-08-13 /pmc/articles/PMC10587635/ /pubmed/37868797 http://dx.doi.org/10.1016/j.xops.2023.100383 Text en © 2023 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Li, Angela S.
Myers, Justin
Stinnett, Sandra S.
Grewal, Dilraj S.
Jaffe, Glenn J.
Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title_full Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title_fullStr Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title_full_unstemmed Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title_short Gradeability and Reproducibility of Geographic Atrophy Measurement in GATHER-1, a Phase II/III Randomized Interventional Trial
title_sort gradeability and reproducibility of geographic atrophy measurement in gather-1, a phase ii/iii randomized interventional trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587635/
https://www.ncbi.nlm.nih.gov/pubmed/37868797
http://dx.doi.org/10.1016/j.xops.2023.100383
work_keys_str_mv AT liangelas gradeabilityandreproducibilityofgeographicatrophymeasurementingather1aphaseiiiiirandomizedinterventionaltrial
AT myersjustin gradeabilityandreproducibilityofgeographicatrophymeasurementingather1aphaseiiiiirandomizedinterventionaltrial
AT stinnettsandras gradeabilityandreproducibilityofgeographicatrophymeasurementingather1aphaseiiiiirandomizedinterventionaltrial
AT grewaldilrajs gradeabilityandreproducibilityofgeographicatrophymeasurementingather1aphaseiiiiirandomizedinterventionaltrial
AT jaffeglennj gradeabilityandreproducibilityofgeographicatrophymeasurementingather1aphaseiiiiirandomizedinterventionaltrial